Tohoku Medical Megabank Project

Tohoku Medical Megabank Project
Name	Tohoku Medical Megabank Project
Formation	2011
Headquarters	Sendai, Miyagi Prefecture
Leader title	Director
Leader name	Satoshi Katayama

Tohoku Medical Megabank Project The Tohoku Medical Megabank Project is a large-scale biomedical research initiative launched after the 2011 Great East Japan Earthquake and 2011 Tōhoku earthquake and tsunami to establish population cohorts, develop genomic resources, and create biobanks to support precision medicine and disaster recovery. The project links regional institutions and national agencies to produce genotype, phenotype, and biospecimen datasets intended for use by researchers studying disease susceptibility, public health, and pharmacogenomics. It integrates strategies from cohort studies, biobanking, and bioinformatics to enable translational research across clinical, epidemiological, and genomic domains.

Overview

The project operates through collaborations among Tohoku University, Iwate Medical University, Fukushima Medical University, Miyagi Prefecture, Miyagi University of Education, and national agencies such as the Ministry of Health, Labour and Welfare (Japan), the Japan Agency for Medical Research and Development, and the National Center for Global Health and Medicine. It established large volunteer cohorts in Miyagi Prefecture and Iwate Prefecture and created high-quality biospecimen repositories located near Sendai, Morioka, and Kesennuma. The initiative interfaces with international efforts including the 1000 Genomes Project, the UK Biobank, the All of Us Research Program, and the International HapMap Project to standardize data formats used by researchers in United States, United Kingdom, China, Germany, France, Singapore, and other countries.

History and Background

The disaster response context traces to the 2011 Tōhoku earthquake and tsunami and subsequent events involving the Fukushima Daiichi nuclear disaster, mobilizing academic recovery programs at Tohoku University Tohoku Medical Megabank Organization, Sendai City Hospital, and regional public health centers. Key figures included academic leaders from Tohoku University Graduate School of Medicine, administrators from the Japan Agency for Medical Research and Development, and policymakers in the Diet of Japan who supported funding measures. Early links were formed with genomic consortia such as the Human Genome Project, the International Cancer Genome Consortium, and the 100,000 Genomes Project to adopt best practices in cohort recruitment, informed consent, and data sharing.

Study Design and Cohorts

The project instituted multiple cohort arms including the Community-Based Cohort and the Birth and Three-Generation Cohort, recruiting participants through municipal health checkups, perinatal clinics, and university hospitals. Recruitment leveraged networks involving Miyagi Prefectural Government, Iwate Prefectural Government, Japan Self-Defense Forces disaster response, and community organizations linked to Japan Red Cross Society and Save the Children Japan. Cohort protocols were influenced by methods from the Framingham Heart Study, Nurses' Health Study, Rotterdam Study, China Kadoorie Biobank, and the Japan Public Health Center-based Prospective Study to capture clinical measures, lifestyle questionnaires, and family pedigrees.

Data Collection and Biobanking

Biospecimens collected include DNA, plasma, serum, and peripheral blood mononuclear cells processed for long-term storage under standards aligned with the International Society for Biological and Environmental Repositories and ISO biobanking norms. Sequencing and genotyping efforts employed platforms from Illumina, Thermo Fisher Scientific, and collaborations with the National Center for Biotechnology Information and the DNA Data Bank of Japan to deposit variant calls and reference panels. Data types encompass whole-genome sequencing, genome-wide association study arrays, methylation assays, metabolomics, and clinical laboratory data harmonized using ontologies from the Global Alliance for Genomics and Health, Human Phenotype Ontology, and the Observational Medical Outcomes Partnership.

Research Activities and Findings

Analyses have produced population-specific reference panels, allele frequency catalogs, and insights into genetic architecture for diseases such as stroke, myocardial infarction, type 2 diabetes, and various cancers, with publications citing comparative frameworks like the Genome-wide association study methodology used in the Wellcome Trust Case Control Consortium outputs. Findings on pharmacogenomic variants informed drug response studies referencing the CYP2D6 and CYP2C19 alleles, and environmental-health research examined implications of radiation exposure drawing on literature from United Nations Scientific Committee on the Effects of Atomic Radiation and World Health Organization assessments. Collaborative projects linked with the Japanese Genotype-Phenotype Archive, the Biobank Japan Project, and international consortia such as the Global Alliance for Genomics and Health have expanded meta-analyses, polygenic risk score development, and translational pipelines toward clinical utility.

Governance, Ethics, and Funding

Governance frameworks include institutional review processes at Tohoku University Hospital Institutional Review Board, data access committees modeled after the European Genome-phenome Archive and policies influenced by the Personal Information Protection Commission (Japan). Ethical oversight addressed issues raised by international declarations like the Declaration of Helsinki, national laws including the Act on the Protection of Personal Information (Japan), and guidelines from the Council for International Organizations of Medical Sciences. Funding combined grants from the Ministry of Education, Culture, Sports, Science and Technology (Japan), the Japan Agency for Medical Research and Development, philanthropic contributions from foundations, and partnerships with industry entities such as Takeda Pharmaceutical Company, Astellas Pharma, and technology providers.

Impact and Future Directions

The project strengthened regional research capacity at institutions like Tohoku University Tohoku Medical Megabank Organization, fostered workforce development through programs involving the Japan Society for the Promotion of Science, and influenced public health resilience strategies tied to disaster preparedness bodies such as the Cabinet Office (Japan) disaster management units. Future directions emphasize integration with clinical genomic services at National Center for Global Health and Medicine, expanded multi-omics, machine learning collaborations with institutes like RIKEN, and international data sharing with platforms including the European Bioinformatics Institute, the National Institutes of Health, and the World Health Organization to advance precision medicine and population health research.

Category:Biobanks in Japan Category:Genomic projects